Log in to save to my catalogue

The Active Metabolite of Clopidogrel Disrupts P2Y12 Receptor Oligomers and Partitions Them out of Li...

The Active Metabolite of Clopidogrel Disrupts P2Y12 Receptor Oligomers and Partitions Them out of Li...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1073_pnas_0510446103

The Active Metabolite of Clopidogrel Disrupts P2Y12 Receptor Oligomers and Partitions Them out of Lipid Rafts

About this item

Full title

The Active Metabolite of Clopidogrel Disrupts P2Y12 Receptor Oligomers and Partitions Them out of Lipid Rafts

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2006-07, Vol.103 (29), p.11069-11074

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

P2Y12, a G protein-coupled receptor that plays a central role in platelet activation has been recently identified as the receptor targeted by the antithrombotic drug, clopidogrel. In this study, we further deciphered the mechanism of action of clopidogrel and of its active metabolite (Act-Met) on P2Y12 receptors. Using biochemical approaches, we de...

Alternative Titles

Full title

The Active Metabolite of Clopidogrel Disrupts P2Y12 Receptor Oligomers and Partitions Them out of Lipid Rafts

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1073_pnas_0510446103

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1073_pnas_0510446103

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.0510446103

How to access this item